Brief: Herantis Pharma Selected For Horizon 2025 Grant

Herantis Pharma Oyj

19/02/2026 15:36

Feb 19 (Reuters) - Herantis Pharma Oyj HRTIS.HE:

HERANTIS PHARMA SELECTED FOR HORIZON 2025 GRANT OF EUR 8.0 MILLION FOR PHASE 2 TRIAL OF HER-096

Source text: https://mfn.se/ind/a/herantis-pharma/inside-information-herantis-pharma-selected-for-horizon-2025-grant-of-eur-8-0-million-for-phase-2-trial-of-her-096-e42e6281

Further company coverage: HRTIS.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))